Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment

• Egile Nagusiak: Pitsiou G (Egilea), Zarogoulidis P (Egilea), Petridis D (Egilea), Kioumis I (Egilea), Lampaki S (Egilea), Organtzis J (Egilea), Porpodis K (Egilea), Papaiwannou A (Egilea), Tsiouda T (Egilea), Hohenforst-Schmidt W (Egilea), Kakolyris S (Egilea), Syrigos K (Egilea), Huang H (Egilea), Li Q (Egilea), Turner JF (Egilea), Zarogoulidis K (Egilea)
• Formatua: Liburua
• Argitaratua: Dove Medical Press, 2014-10-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Georgia Pitsiou,1 Paul Zarogoulidis,1 Dimitris Petridis,2 Ioannis Kioumis,1 Sofia Lampaki,1 John Organtzis,1 Konstantinos Porpodis,1 Antonis Papaiwannou,1 Theodora Tsiouda,3 Wolfgang Hohenforst-Schmidt,4 Stylianos Kakolyris,5 Konstantinos Syrigos,6 Haidong Huang,7 Qiang Li,7 J Francis Turner,8 Konst...